Global Oral Antiviral Medicines for COVID-19 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Oral Antiviral Medicines for COVID-19 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Antiviral Medicines for COVID-19 report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Oral Antiviral Medicines for COVID-19 market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Aldult and Elder are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Antiviral Medicines for COVID-19 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Oral Antiviral Medicines for COVID-19 key manufacturers include Pfizer, Merck, Shionogi, Simcere Pharmaceutical, Frontier Biotechnologies and Kexing Biopharm, etc. Pfizer, Merck, Shionogi are top 3 players and held % sales share in total in 2023.
Oral Antiviral Medicines for COVID-19 can be divided into Lagevrio, Paxlovid and Azvudine,, etc. Lagevrio is the mainstream product in the market, accounting for % sales share globally in 2023.
Oral Antiviral Medicines for COVID-19 is widely used in various fields, such as Aldult and Elder, etc. Aldult provides greatest supports to the Oral Antiviral Medicines for COVID-19 industry development. In 2023, global % sales of Oral Antiviral Medicines for COVID-19 went into Aldult filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Oral Antiviral Medicines for COVID-19 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
Merck
Shionogi
Simcere Pharmaceutical
Frontier Biotechnologies
Kexing Biopharm
Segment by Type
Lagevrio
Paxlovid
Azvudine
Aldult
Elder
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Antiviral Medicines for COVID-19 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Antiviral Medicines for COVID-19, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Antiviral Medicines for COVID-19 industry.
Chapter 3Historical (2018-2023) and forecast (2023-2033) volume and revenue analysis of Oral Antiviral Medicines for COVID-19 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Antiviral Medicines for COVID-19 introduction, etc. Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRA Research’s Conclusions of Oral Antiviral Medicines for COVID-19 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRA Research.
North America, Europe and Asia Pacific are the key regions for Oral Antiviral Medicines for COVID-19 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Oral Antiviral Medicines for COVID-19 key manufacturers include Pfizer, Merck, Shionogi, Simcere Pharmaceutical, Frontier Biotechnologies and Kexing Biopharm, etc. Pfizer, Merck, Shionogi are top 3 players and held % sales share in total in 2023.
Oral Antiviral Medicines for COVID-19 can be divided into Lagevrio, Paxlovid and Azvudine,, etc. Lagevrio is the mainstream product in the market, accounting for % sales share globally in 2023.
Oral Antiviral Medicines for COVID-19 is widely used in various fields, such as Aldult and Elder, etc. Aldult provides greatest supports to the Oral Antiviral Medicines for COVID-19 industry development. In 2023, global % sales of Oral Antiviral Medicines for COVID-19 went into Aldult filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Oral Antiviral Medicines for COVID-19 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
Merck
Shionogi
Simcere Pharmaceutical
Frontier Biotechnologies
Kexing Biopharm
Segment by Type
Lagevrio
Paxlovid
Azvudine
Segment by Application
Aldult
Elder
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Antiviral Medicines for COVID-19 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Antiviral Medicines for COVID-19, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Antiviral Medicines for COVID-19 industry.
Chapter 3Historical (2018-2023) and forecast (2023-2033) volume and revenue analysis of Oral Antiviral Medicines for COVID-19 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Antiviral Medicines for COVID-19 introduction, etc. Oral Antiviral Medicines for COVID-19 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRA Research’s Conclusions of Oral Antiviral Medicines for COVID-19 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRA Research.